Glenmark Generics Limited, a amalgamated public limited company, was established on 29 September 1994 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24110MH1994PLC081597. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹200.00 Cr and a paid-up capital of ₹151.07 Cr.
Its leadership includes Natvarlal Bhimbhai Desai (Director), Glenn Mario Saldanha (Director), Jalaj Sharma (Whole-Time Director). Past directors included Natvarlal Bhimbhai Desai, Glenn Mario Saldanha, Blanche Saldanha Elizabeth. Its latest AGM occurred on 22 July 2014, with the balance sheet filed on 31 March 2014. It is based at B/2, Mahalaxmi Chambers22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026.
U24110MH1994PLC081597
081597
29 September 1994
₹200.00 Cr
₹151.07 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Glenmark Generics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Natvarlal Bhimbhai Desai | Director | 14 Aug 2009 | Current |
| Glenn Mario Saldanha | Director | 18 Dec 2007 | Current |
| Jalaj Sharma | Whole-Time Director | 01 Apr 2009 | Current |
| Rajesh Vasudeo Desai | Director | 14 Aug 2009 | Current |
| Sridhar Gorthi | Director Appointed In Casual Vacancy | 14 Aug 2008 | Current |
| Julio Francis Ribeiro | Director Appointed In Casual Vacancy | 14 Aug 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Jun 2010 | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2008 | Past |
| Pramod Abcsdd | Director | 05 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2010 | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2008 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Glenmark Generics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Glenmark Generics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Glenmark Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glenmark Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenmark Generics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Glenmark Generics Limited last Annual general meeting of members was held on 22 Jul 2014 as per latest MCA records. was documented.
Glenmark Generics Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai. was recorded as a recent event.
The activity Rudalf Joseph Corriea was appointed as a Company Secretary was appointed as a Company Secretary on 01 May 2013 & has been associated with this company since 12 years 7 months . was completed.
The activity Natvarlal Bhimbhai Desai was appointed as a Director was appointed as a Director on 14 Aug 2009 & has been associated with this company since 16 years 3 months . was completed.
Rajesh Vasudeo Desai was appointed as a Director was appointed as a Director on 14 Aug 2009 & has been associated with this company since 16 years 3 months . was recorded as a recent event.
Devendra Raj Mehta was appointed as a Director was appointed as a Director on 14 Aug 2009 & has been associated with this company since 16 years 3 months . was recorded as a recent event.
The CIN of Glenmark Generics Limited is U24110MH1994PLC081597.
Glenmark Generics Limited is headquartered at B/2, Mahalaxmi Chambers22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026.
Glenmark Generics Limited was incorporated on 29 September 1994.
The current directors of Glenmark Generics Limited are
The primary industry of Glenmark Generics Limited is Pharma.
Glenmark Generics Limited is unlisted.
The authorized capital of Glenmark Generics Limited is ₹200.00 Cr, and the paid-up capital is ₹151.07 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX